Lüdicke F et al. |
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. |
2015 |
Biomarkers |
pmid:26616146
|
Milani M et al. |
Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. |
1996 |
Biomed. Pharmacother. |
pmid:8952866
|
Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|
Wang ZY et al. |
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. |
2001 |
Blood Coagul. Fibrinolysis |
pmid:11685040
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Bridges AB et al. |
Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. |
1991 |
Blood Coagul. Fibrinolysis |
pmid:1932530
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Ferretti A and Flanagan VP |
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. |
1995 |
Chem. Phys. Lipids |
pmid:7586090
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Kurokawa K et al. |
Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. |
2001 |
Chest |
pmid:11742908
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|